Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009:330:173-89.
doi: 10.1007/978-3-540-70617-5_9.

Measles control and the prospect of eradication

Affiliations
Review

Measles control and the prospect of eradication

W J Moss. Curr Top Microbiol Immunol. 2009.

Abstract

Remarkable progress has been made in reducing measles incidence and mortality as a consequence of implementing the measles mortality reduction strategy of the World Health Organization (WHO) and United Nations Children's Fund (UNICEF). The revised global measles mortality reduction goal set forth in the WHO-UNICEF Global Immunization Vision and Strategy for 2006-2015 is to reduce measles deaths by 90% by 2010 compared to the estimated 757,000 deaths in 2000. The possibility of measles eradication has been discussed for almost 40 years, and measles meets many of the criteria for eradication. Global measles eradication will face a number of challenges to achieving and sustaining high levels of vaccine coverage and population immunity, including population growth and demographic changes, conflict and political instability, and public perceptions of vaccine safety. To achieve the measles mortality reduction goal, continued progress needs to be made in delivering measles vaccines to the world's children.

PubMed Disclaimer

References

    1. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357:1903–1915. doi: 10.1056/NEJMoa066092. - DOI - PubMed
    1. Andrews N, Tischer A, Siedler A, Pebody RG, Barbara C, Cotter S, Duks A, Gacheva N, Bohumir K, Johansen K, Mossong J, Ory F, Prosenc K, Slacikova M, Theeten H, Zarvou M, Pistol A, Bartha K, Cohen D, Backhouse J, Griskevicius A. Towards elimination: measles susceptibility in Australia and 17 European countries. Bull World Health Organ. 2008;86:197–204. doi: 10.2471/BLT.07.043034. - DOI - PMC - PubMed
    1. Angel JB, Walpita P, Lerch RA, Sidhu MS, Masuredar M, DeLellis RA, Noble JT, Snydman DR, Udem SA. Vaccine-associated measles pneumonitis in an adult with AIDS. Ann Intern Med. 1998;129:104–106. - PubMed
    1. Bellini WJ, Helfand RF. The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis. 2003;187:S283–S290. doi: 10.1086/368040. - DOI - PubMed
    1. Biellik R, Madema S, Taole A, Allies A, Kutsulukuta A, Eggers R, Ngcobo N, Nxumalo M, Shearley A, Mabuzane E, Kufa E, Okwo-Bele JM. First 5 years of measles elimination in southern Africa: 1996–2000. Lancet. 2002;359:1564–1568. doi: 10.1016/S0140-6736(02)08517-3. - DOI - PubMed

Substances